I was pondering the AMBS and AVDX transaction.
Assume
I was pondering the AMBS and AVDX transaction.
Assume for a second that Gerald is not a sociopath and a pathological liar. If that is true, we are all screwed. I don't think it is.
I think he had some good preliminary talks with people interested in our Diagnostic assets. Then he became really arrogant and started tweeting claims which eventually turned out to appear outlandish given the performance of the stock and the lack of any real diagnostic deal.
No real deal happened because of the toxic soup that is AMBS.
But Gerald promised us all a deal. So he decided to throw the assets into a publicly traded OTC company that is very close to a shell (only one asset and one employee). And from watching his presentation, that one employee is a complete disaster who knew close to nothing about our diagnostic assets at the time of the signing of the LOI.
I think that Gerald believes he can bring the players with interest in our Diagnostic assets back to the table if he can offer them up through a clean entity - AVDX.
That's my hope at least. If that isn't what he is doing, and he actually choose to get in bed with AVDX as a viable deal on its own, again we are all screwed.
7
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...
Continue Reading
Trimble Smashes Through Q3 Expectations Trimble Inc. (NASDAQ:TRMB) tossed a bit of a curveball by posting Q3 2026 results that sailed past analyst forecasts. We’re talking revenue swelling to $966.8 million, a decent 7% bump from the previous year. Now, for a company riding its 'Connect & Scale' strategy, this serves as a validation of its aggressive scaling ambitions....
Continue Reading
Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...
Continue Reading
Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...
Continue Reading
Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...
Continue Reading
Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...
Continue Reading
Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...
Continue Reading
Allego Secures Top Spot Yet Again I've seen companies rise and fall on the whims of industry recognition, and let me tell ya, Allego's riding high on the right wave. For the second year running, this outfit's been named a Leader in the 2026 Gartner Magic Quadrant for Revenue Enablement Platforms. Recognized for its Completeness of Vision—yeah, that's no small feat...
Continue Reading
What's Roaring: The Latest from KOVE Anybody who’s been following motorcycle trends knows that EICMA 2026 was destined to be a spectacle, and KOVE didn’t disappoint. They rolled out a fleet of five new models, including the 125 RALLY, 350 RALLY, 650RR, and two head-turners on the electric front: the BONIC and the E-500RR. Each model brings something fresh to the...
Continue Reading
Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...
Continue Reading
Top 5 Most Recently Viewed Articles
Tesla's Earnings and Market Dynamics As we gear up for Tesla's earnings announcement, all eyes are turning to the electric vehicle giant (NASDAQ: TSLA). Tesla is leading the charge as the first among the prominent group of tech companies known as the "Magnificent Seven" to reveal its financial performance. The anticipation builds as markets reflect on how business...
Continue Reading
Atos Group Updates on Financial Performance for 2025 Availability of the 2025 Half-year Financial Report Atos Group has made significant strides in its financial reporting for 2025, announcing the release of its half-year financial report. This document was published on the Atos website and was also filed with the French Financial Markets Authority (AMF). Insights from...
Continue Reading
Anywhere Real Estate's Exciting New Partnership Anywhere Real Estate Inc. (NYSE: HOUS), a global frontrunner in the residential real estate sector, has recently unveiled an impactful collaboration with Canva, a recognized visual communication platform. This agreement aims to empower Every agent within their extensive network. Enhanced Tools for Affiliated Agents This...
Continue Reading
THEON Unveils Revolutionary A.R.M.E.D. Ecosystem At IDEX 2025, THEON made a significant impact by showcasing its A.R.M.E.D. (Augmented Reality Modular Ecosystem of Devices), designed to elevate the capabilities of tomorrow's soldiers. This integrated solution promises to improve tactical awareness, effectiveness, and survivability for modern combat operatives....
Continue Reading
4th International Symposium on Arthrogryposis Unveiled in Montreal MONTREAL — The Shriners Hospitals for Children - Canada is set to host the much-anticipated 4th International Symposium on Arthrogryposis from September 28 to October 1. This initiative brings together renowned healthcare professionals and researchers from various pediatric centers in Montreal,...
Continue Reading